Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test

Detalles Bibliográficos
Autores principales: Waterboer, Tim, Brenner, Nicole, Klussmann, Jens P., Brennan, Paul, Wieland, Ulrike, Robbins, Hilary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701317/
https://www.ncbi.nlm.nih.gov/pubmed/33249381
http://dx.doi.org/10.1016/j.ebiom.2020.103143
_version_ 1783616469239595008
author Waterboer, Tim
Brenner, Nicole
Klussmann, Jens P.
Brennan, Paul
Wieland, Ulrike
Robbins, Hilary A.
author_facet Waterboer, Tim
Brenner, Nicole
Klussmann, Jens P.
Brennan, Paul
Wieland, Ulrike
Robbins, Hilary A.
author_sort Waterboer, Tim
collection PubMed
description
format Online
Article
Text
id pubmed-7701317
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77013172020-12-07 Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test Waterboer, Tim Brenner, Nicole Klussmann, Jens P. Brennan, Paul Wieland, Ulrike Robbins, Hilary A. EBioMedicine Letter Elsevier 2020-11-27 /pmc/articles/PMC7701317/ /pubmed/33249381 http://dx.doi.org/10.1016/j.ebiom.2020.103143 Text en © 2020 Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/3.0/igo/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/igo/).
spellingShingle Letter
Waterboer, Tim
Brenner, Nicole
Klussmann, Jens P.
Brennan, Paul
Wieland, Ulrike
Robbins, Hilary A.
Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
title Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
title_full Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
title_fullStr Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
title_full_unstemmed Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
title_short Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
title_sort study results and related evidence do not support use of hpv16 l1 drh1 antibodies as a cancer screening test
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701317/
https://www.ncbi.nlm.nih.gov/pubmed/33249381
http://dx.doi.org/10.1016/j.ebiom.2020.103143
work_keys_str_mv AT waterboertim studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest
AT brennernicole studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest
AT klussmannjensp studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest
AT brennanpaul studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest
AT wielandulrike studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest
AT robbinshilarya studyresultsandrelatedevidencedonotsupportuseofhpv16l1drh1antibodiesasacancerscreeningtest

Ejemplares similares